1Christie M,Brown T J, Cassidy D. Binding of antibodies in sera from type Ⅰ diabetic patients to glutamate decarboxylase from rat tissue.evidence for antigenic and non-antigenic froms of the enzyme. Diabetologia,1992,35:380 - 384.
2Maugendre D,Verite F, Guilhem I,et al. Anti-pancreatic autoimmunity and Graves' disease:study of a cohort of 600 Caucasian patients. Eur J Endocrinol, 1997, 137:503-510.
3Kusaka I, Nagasaka S, Fujibayshi K, et al. Immunologically related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement. Endocrine, 1999,46: 747-754.
4Tuomi T, Groop LC, Zimmet PZ. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease [J]. Diabetes, 1993,42(2): 359-62.
5Hawa MI, Notkins AL, Fava D, et al. Antibodies to IA-2 and GAD65in type 1 and type 2 diabetes isotye restriction and polyclonality [J].Diabetes Care, 2000, 23(2): 228-33.
6Pietropaolo M, Marinas-Mitchell E, Pietropaolo SL, et al. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes[J]. Diabetes, 2000, 49(1): 32-8.
7Isomaa B, Almgren P, Henricsson M, et al. Chronic complication in patients with slowly progressing autoimmune type 1 diabetes (LADA)[J]. Diabetes Care, 1999, 22(11): 1347-53.
